Search research articles
Contact Us
Filters
Showing results (171-180 of 191) with videos related to
Page
of 20
Sort By:
Hematology (Amsterdam, Netherlands)
|
September 19, 2023
The age-dependent changes in risk weights of the prognostic factors for multiple myeloma
Chenxing Du, Lingna Li, Huishou Fan, et al.
Haematologica
|
May 2, 2024
Minimal residual disease monitoring in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia: prognostic significance and correlation between multiparameter flow cytometry and real-time quantitative polymerase chain reaction
Jun Li, Anni Lu, Yangyang Gao, et al.
British Journal of Haematology
|
December 28, 2022
Impact of the International Consensus Classification of myelodysplastic syndromes
Yudi Zhang, Junying Wu, Zefeng Xu, et al.
Experimental Hematology & Oncology
|
October 17, 2022
IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes
Junying Wu, Yudi Zhang, Tiejun Qin, et al.
Zhonghua Nei Ke Za Zhi
|
February 16, 2016
[A clinical study of acute lymphoblastic leukemia in adolescents: a single center experience]
Kaiqi Liu, Xingli Zhao, Hui Wei, et al.
Blood Science (Baltimore, Md.)
|
May 25, 2023
Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma
Ru Li, Tingyu Wang, Rui Lyv, et al.
Oncotarget
|
October 31, 2015
High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival
Shuhua Yi, Dehui Zou, Chengwen Li, et al.
Oncotarget
|
February 10, 2018
Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders
Shuhua Yi, Zengjun Li, Dehui Zou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 10, 2011
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector
Dawn E Bowles, Scott W J McPhee, Chengwen Li, et al.
Annals of Hematology
|
April 19, 2022
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant
Yi Wang, Tingyu Wang, Ying Yu, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 191) with videos related to
Sort By:
Page
of 20
Hematology (Amsterdam, Netherlands)
|
September 19, 2023
The age-dependent changes in risk weights of the prognostic factors for multiple myeloma
Chenxing Du, Lingna Li, Huishou Fan, et al.
Haematologica
|
May 2, 2024
Minimal residual disease monitoring in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia: prognostic significance and correlation between multiparameter flow cytometry and real-time quantitative polymerase chain reaction
Jun Li, Anni Lu, Yangyang Gao, et al.
British Journal of Haematology
|
December 28, 2022
Impact of the International Consensus Classification of myelodysplastic syndromes
Yudi Zhang, Junying Wu, Zefeng Xu, et al.
Experimental Hematology & Oncology
|
October 17, 2022
IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes
Junying Wu, Yudi Zhang, Tiejun Qin, et al.
Zhonghua Nei Ke Za Zhi
|
February 16, 2016
[A clinical study of acute lymphoblastic leukemia in adolescents: a single center experience]
Kaiqi Liu, Xingli Zhao, Hui Wei, et al.
Blood Science (Baltimore, Md.)
|
May 25, 2023
Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma
Ru Li, Tingyu Wang, Rui Lyv, et al.
Oncotarget
|
October 31, 2015
High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival
Shuhua Yi, Dehui Zou, Chengwen Li, et al.
Oncotarget
|
February 10, 2018
Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders
Shuhua Yi, Zengjun Li, Dehui Zou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 10, 2011
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector
Dawn E Bowles, Scott W J McPhee, Chengwen Li, et al.
Annals of Hematology
|
April 19, 2022
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant
Yi Wang, Tingyu Wang, Ying Yu, et al.
Page
of 20